Skip to main content

Table 2 Risk of bias summary of controlled trials of quetiapine in major depressive disorder

From: Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials

Study

Issues of bias

1

2

3

4

5

6

7

8

Cutler AJ 2009

N

N

N

N

N

N

N

N

Weisler R 2009

N

N

N

N

N

N

N

N

Bortnick B 2011

N/A

N/A

N

N

N

N

N

N

  1. 1=Adequate sequence generation; 2 = Allocation concealment; 3=Blinding (Subjective outcome); 4 = Dropout data addressed; 5 = Free of selective reporting; 6 = Free of other bias; 7 = Baseline similarity; 8 = Intention-to-treat analysis or modified intention-to-treat analysis; N/A = not available; N = No risk of bias.